nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—Hydrocortisone—psoriasis	0.353	1	CrCtD
Eplerenone—CYP11B2—Hydrocortisone—psoriasis	0.0617	0.222	CbGbCtD
Eplerenone—NR3C2—Betamethasone—psoriasis	0.046	0.165	CbGbCtD
Eplerenone—NR3C2—Prednisolone—psoriasis	0.0454	0.163	CbGbCtD
Eplerenone—NR3C2—Dexamethasone—psoriasis	0.0267	0.096	CbGbCtD
Eplerenone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.0185	0.0631	CrCrCtD
Eplerenone—Fludrocortisone—Clobetasol propionate—psoriasis	0.0181	0.0614	CrCrCtD
Eplerenone—Hydrocortamate—Beclomethasone—psoriasis	0.0172	0.0584	CrCrCtD
Eplerenone—CYP3A5—Beclomethasone—psoriasis	0.0159	0.057	CbGbCtD
Eplerenone—Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.0141	0.0478	CrCrCtD
Eplerenone—Drospirenone—Hydrocortisone—psoriasis	0.0121	0.041	CrCrCtD
Eplerenone—Spironolactone—Hydrocortisone—psoriasis	0.0115	0.039	CrCrCtD
Eplerenone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00934	0.0318	CrCrCtD
Eplerenone—Hydrocortamate—Hydrocortisone—psoriasis	0.00843	0.0287	CrCrCtD
Eplerenone—Cortisone acetate—Hydrocortisone—psoriasis	0.00817	0.0278	CrCrCtD
Eplerenone—Fluoxymesterone—Hydrocortisone—psoriasis	0.00729	0.0248	CrCrCtD
Eplerenone—Hydrocortamate—Prednisone—psoriasis	0.00726	0.0247	CrCrCtD
Eplerenone—Progesterone—Hydrocortisone—psoriasis	0.0071	0.0241	CrCrCtD
Eplerenone—Testosterone Propionate—Hydrocortisone—psoriasis	0.0071	0.0241	CrCrCtD
Eplerenone—Fludrocortisone—Hydrocortisone—psoriasis	0.0071	0.0241	CrCrCtD
Eplerenone—Hydrocortamate—Prednisolone—psoriasis	0.00709	0.0241	CrCrCtD
Eplerenone—Cortisone acetate—Prednisone—psoriasis	0.00704	0.0239	CrCrCtD
Eplerenone—Methyltestosterone—Hydrocortisone—psoriasis	0.00692	0.0235	CrCrCtD
Eplerenone—Cortisone acetate—Prednisolone—psoriasis	0.00687	0.0234	CrCrCtD
Eplerenone—Fluoxymesterone—Betamethasone—psoriasis	0.00677	0.023	CrCrCtD
Eplerenone—Fluoxymesterone—Dexamethasone—psoriasis	0.00677	0.023	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00676	0.0243	CbGbCtD
Eplerenone—CYP3A7—Hydrocortisone—psoriasis	0.00676	0.0243	CbGbCtD
Eplerenone—Fluoxymesterone—Triamcinolone—psoriasis	0.00661	0.0225	CrCrCtD
Eplerenone—Fludrocortisone—Betamethasone—psoriasis	0.00659	0.0224	CrCrCtD
Eplerenone—Fludrocortisone—Dexamethasone—psoriasis	0.00659	0.0224	CrCrCtD
Eplerenone—Fludrocortisone—Triamcinolone—psoriasis	0.00644	0.0219	CrCrCtD
Eplerenone—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00639	0.0229	CbGbCtD
Eplerenone—CYP3A7—Cyclosporine—psoriasis	0.00639	0.0229	CbGbCtD
Eplerenone—CYP3A5—Mycophenolate mofetil—psoriasis	0.00632	0.0227	CbGbCtD
Eplerenone—Testosterone—Hydrocortisone—psoriasis	0.00616	0.021	CrCrCtD
Eplerenone—Fluoxymesterone—Prednisolone—psoriasis	0.00613	0.0208	CrCrCtD
Eplerenone—Fludrocortisone—Prednisone—psoriasis	0.00611	0.0208	CrCrCtD
Eplerenone—Fludrocortisone—Prednisolone—psoriasis	0.00597	0.0203	CrCrCtD
Eplerenone—Progesterone—Prednisolone—psoriasis	0.00597	0.0203	CrCrCtD
Eplerenone—Methyltestosterone—Prednisone—psoriasis	0.00596	0.0203	CrCrCtD
Eplerenone—Methyltestosterone—Prednisolone—psoriasis	0.00582	0.0198	CrCrCtD
Eplerenone—CYP3A4—Calcitriol—psoriasis	0.00552	0.0198	CbGbCtD
Eplerenone—Hydrocortisone—Dexamethasone—psoriasis	0.00538	0.0183	CrCrCtD
Eplerenone—Hydrocortisone—Betamethasone—psoriasis	0.00538	0.0183	CrCrCtD
Eplerenone—Hydrocortisone—Triamcinolone—psoriasis	0.00525	0.0179	CrCrCtD
Eplerenone—Testosterone—Prednisolone—psoriasis	0.00518	0.0176	CrCrCtD
Eplerenone—CYP3A5—Hydrocortisone—psoriasis	0.00507	0.0182	CbGbCtD
Eplerenone—Hydrocortisone—Prednisone—psoriasis	0.00499	0.017	CrCrCtD
Eplerenone—Hydrocortisone—Prednisolone—psoriasis	0.00487	0.0166	CrCrCtD
Eplerenone—CYP3A5—Cyclosporine—psoriasis	0.00479	0.0172	CbGbCtD
Eplerenone—CYP3A4—Methoxsalen—psoriasis	0.00429	0.0154	CbGbCtD
Eplerenone—CYP3A7—Dexamethasone—psoriasis	0.00421	0.0151	CbGbCtD
Eplerenone—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00421	0.0151	CbGbCtD
Eplerenone—CYP3A5—Dexamethasone—psoriasis	0.00316	0.0113	CbGbCtD
Eplerenone—CYP3A4—Cholecalciferol—psoriasis	0.00284	0.0102	CbGbCtD
Eplerenone—CYP3A4—Mycophenolate mofetil—psoriasis	0.00247	0.00885	CbGbCtD
Eplerenone—CYP3A4—Triamcinolone—psoriasis	0.00247	0.00885	CbGbCtD
Eplerenone—CYP3A4—Betamethasone—psoriasis	0.00212	0.00759	CbGbCtD
Eplerenone—CYP3A4—Prednisolone—psoriasis	0.00209	0.00749	CbGbCtD
Eplerenone—CYP3A4—Hydrocortisone—psoriasis	0.00198	0.0071	CbGbCtD
Eplerenone—CYP3A4—Prednisone—psoriasis	0.00197	0.00708	CbGbCtD
Eplerenone—CYP3A4—Cyclosporine—psoriasis	0.00187	0.00671	CbGbCtD
Eplerenone—CYP3A4—Dexamethasone—psoriasis	0.00123	0.00442	CbGbCtD
Eplerenone—NR3C2—ACE Inhibitor Pathway—REN—psoriasis	0.00105	0.119	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—REN—psoriasis	0.00086	0.097	CbGpPWpGaD
Eplerenone—NR3C2—ACE Inhibitor Pathway—ACE—psoriasis	0.000656	0.074	CbGpPWpGaD
Eplerenone—CYP11B2—ACE Inhibitor Pathway—ACE—psoriasis	0.000537	0.0605	CbGpPWpGaD
Eplerenone—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.000532	0.06	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000521	0.0587	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000514	0.058	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000422	0.0476	CbGpPWpGaD
Eplerenone—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000384	0.0434	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—CYP2S1—psoriasis	0.000224	0.0253	CbGpPWpGaD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP2S1—psoriasis	0.000221	0.0249	CbGpPWpGaD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000221	0.0249	CbGpPWpGaD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000218	0.0246	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000211	0.0239	CbGpPWpGaD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000179	0.0202	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000179	0.0202	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00016	0.018	CbGpPWpGaD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000158	0.0178	CbGpPWpGaD
Eplerenone—NR3C2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000147	0.0166	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000129	0.0146	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—CYP2S1—psoriasis	9.51e-05	0.0107	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	9.38e-05	0.0106	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—TARS—psoriasis	9.36e-05	0.0106	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.42e-05	0.00837	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.32e-05	0.00826	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP2S1—psoriasis	6.87e-05	0.00775	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	6.78e-05	0.00765	CbGpPWpGaD
Eplerenone—NR3C2—Generic Transcription Pathway—CARM1—psoriasis	6.12e-05	0.0069	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.02e-05	0.00679	CbGpPWpGaD
Eplerenone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	5.93e-05	0.00669	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—NDUFA5—psoriasis	4.51e-05	0.00509	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.2e-05	0.00474	CbGpPWpGaD
Eplerenone—Insomnia—Mycophenolate mofetil—psoriasis	3.97e-05	0.000607	CcSEcCtD
Eplerenone—Dyspepsia—Cyclosporine—psoriasis	3.96e-05	0.000605	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisolone—psoriasis	3.96e-05	0.000605	CcSEcCtD
Eplerenone—Nausea—Hydroxyurea—psoriasis	3.95e-05	0.000603	CcSEcCtD
Eplerenone—Pruritus—Mycophenolic acid—psoriasis	3.94e-05	0.000601	CcSEcCtD
Eplerenone—Shock—Hydrocortisone—psoriasis	3.94e-05	0.000601	CcSEcCtD
Eplerenone—Myalgia—Triamcinolone—psoriasis	3.93e-05	0.0006	CcSEcCtD
Eplerenone—Nervous system disorder—Hydrocortisone—psoriasis	3.92e-05	0.000599	CcSEcCtD
Eplerenone—Pneumonia—Methotrexate—psoriasis	3.92e-05	0.000599	CcSEcCtD
Eplerenone—Dyspnoea—Mycophenolate mofetil—psoriasis	3.92e-05	0.000598	CcSEcCtD
Eplerenone—Infestation NOS—Methotrexate—psoriasis	3.9e-05	0.000596	CcSEcCtD
Eplerenone—Infestation—Methotrexate—psoriasis	3.9e-05	0.000596	CcSEcCtD
Eplerenone—Depression—Methotrexate—psoriasis	3.89e-05	0.000594	CcSEcCtD
Eplerenone—Flushing—Prednisone—psoriasis	3.89e-05	0.000594	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Cyclosporine—psoriasis	3.89e-05	0.000594	CcSEcCtD
Eplerenone—Skin disorder—Hydrocortisone—psoriasis	3.89e-05	0.000594	CcSEcCtD
Eplerenone—Ill-defined disorder—Betamethasone—psoriasis	3.89e-05	0.000593	CcSEcCtD
Eplerenone—Ill-defined disorder—Dexamethasone—psoriasis	3.89e-05	0.000593	CcSEcCtD
Eplerenone—Discomfort—Triamcinolone—psoriasis	3.88e-05	0.000593	CcSEcCtD
Eplerenone—Fatigue—Cyclosporine—psoriasis	3.88e-05	0.000593	CcSEcCtD
Eplerenone—Hyperhidrosis—Hydrocortisone—psoriasis	3.87e-05	0.000591	CcSEcCtD
Eplerenone—Dyspepsia—Mycophenolate mofetil—psoriasis	3.87e-05	0.00059	CcSEcCtD
Eplerenone—Pain—Cyclosporine—psoriasis	3.85e-05	0.000588	CcSEcCtD
Eplerenone—Constipation—Cyclosporine—psoriasis	3.85e-05	0.000588	CcSEcCtD
Eplerenone—Renal failure—Methotrexate—psoriasis	3.84e-05	0.000586	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CYP2S1—psoriasis	3.83e-05	0.00432	CbGpPWpGaD
Eplerenone—Angioedema—Betamethasone—psoriasis	3.83e-05	0.000584	CcSEcCtD
Eplerenone—Angioedema—Dexamethasone—psoriasis	3.83e-05	0.000584	CcSEcCtD
Eplerenone—Diarrhoea—Mycophenolic acid—psoriasis	3.81e-05	0.000581	CcSEcCtD
Eplerenone—Angiopathy—Prednisone—psoriasis	3.8e-05	0.000581	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	3.79e-05	0.000579	CcSEcCtD
Eplerenone—Malaise—Dexamethasone—psoriasis	3.78e-05	0.000577	CcSEcCtD
Eplerenone—Malaise—Betamethasone—psoriasis	3.78e-05	0.000577	CcSEcCtD
Eplerenone—Syncope—Dexamethasone—psoriasis	3.76e-05	0.000574	CcSEcCtD
Eplerenone—Syncope—Betamethasone—psoriasis	3.76e-05	0.000574	CcSEcCtD
Eplerenone—Constipation—Mycophenolate mofetil—psoriasis	3.76e-05	0.000574	CcSEcCtD
Eplerenone—Pain—Mycophenolate mofetil—psoriasis	3.76e-05	0.000574	CcSEcCtD
Eplerenone—Infection—Triamcinolone—psoriasis	3.74e-05	0.000572	CcSEcCtD
Eplerenone—Hypotension—Hydrocortisone—psoriasis	3.74e-05	0.000571	CcSEcCtD
Eplerenone—Haematuria—Methotrexate—psoriasis	3.72e-05	0.000568	CcSEcCtD
Eplerenone—Feeling abnormal—Cyclosporine—psoriasis	3.71e-05	0.000567	CcSEcCtD
Eplerenone—Shock—Triamcinolone—psoriasis	3.71e-05	0.000566	CcSEcCtD
Eplerenone—Insomnia—Prednisolone—psoriasis	3.71e-05	0.000566	CcSEcCtD
Eplerenone—Hepatobiliary disease—Methotrexate—psoriasis	3.69e-05	0.000563	CcSEcCtD
Eplerenone—Gastrointestinal pain—Cyclosporine—psoriasis	3.68e-05	0.000562	CcSEcCtD
Eplerenone—Loss of consciousness—Dexamethasone—psoriasis	3.68e-05	0.000562	CcSEcCtD
Eplerenone—Loss of consciousness—Betamethasone—psoriasis	3.68e-05	0.000562	CcSEcCtD
Eplerenone—Dizziness—Mycophenolic acid—psoriasis	3.68e-05	0.000562	CcSEcCtD
Eplerenone—Mental disorder—Prednisone—psoriasis	3.67e-05	0.000561	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—VDR—psoriasis	3.65e-05	0.00412	CbGpPWpGaD
Eplerenone—Malnutrition—Prednisone—psoriasis	3.65e-05	0.000557	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	3.65e-05	0.000557	CcSEcCtD
Eplerenone—Hyperhidrosis—Triamcinolone—psoriasis	3.64e-05	0.000556	CcSEcCtD
Eplerenone—Feeling abnormal—Mycophenolate mofetil—psoriasis	3.62e-05	0.000553	CcSEcCtD
Eplerenone—Insomnia—Hydrocortisone—psoriasis	3.62e-05	0.000553	CcSEcCtD
Eplerenone—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	3.59e-05	0.000548	CcSEcCtD
Eplerenone—Myalgia—Dexamethasone—psoriasis	3.57e-05	0.000545	CcSEcCtD
Eplerenone—Myalgia—Betamethasone—psoriasis	3.57e-05	0.000545	CcSEcCtD
Eplerenone—Abdominal pain—Cyclosporine—psoriasis	3.56e-05	0.000544	CcSEcCtD
Eplerenone—Body temperature increased—Cyclosporine—psoriasis	3.56e-05	0.000544	CcSEcCtD
Eplerenone—Vomiting—Mycophenolic acid—psoriasis	3.54e-05	0.00054	CcSEcCtD
Eplerenone—Discomfort—Dexamethasone—psoriasis	3.52e-05	0.000538	CcSEcCtD
Eplerenone—Discomfort—Betamethasone—psoriasis	3.52e-05	0.000538	CcSEcCtD
Eplerenone—Dyspepsia—Hydrocortisone—psoriasis	3.52e-05	0.000538	CcSEcCtD
Eplerenone—Rash—Mycophenolic acid—psoriasis	3.51e-05	0.000536	CcSEcCtD
Eplerenone—Dermatitis—Mycophenolic acid—psoriasis	3.51e-05	0.000535	CcSEcCtD
Eplerenone—Pain—Prednisolone—psoriasis	3.5e-05	0.000535	CcSEcCtD
Eplerenone—Headache—Mycophenolic acid—psoriasis	3.49e-05	0.000532	CcSEcCtD
Eplerenone—Pharyngitis—Methotrexate—psoriasis	3.48e-05	0.000531	CcSEcCtD
Eplerenone—Abdominal pain—Mycophenolate mofetil—psoriasis	3.47e-05	0.00053	CcSEcCtD
Eplerenone—Body temperature increased—Mycophenolate mofetil—psoriasis	3.47e-05	0.00053	CcSEcCtD
Eplerenone—Urinary tract disorder—Methotrexate—psoriasis	3.46e-05	0.000528	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Hydrocortisone—psoriasis	3.45e-05	0.000528	CcSEcCtD
Eplerenone—Fatigue—Hydrocortisone—psoriasis	3.45e-05	0.000527	CcSEcCtD
Eplerenone—Urethral disorder—Methotrexate—psoriasis	3.43e-05	0.000524	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Triamcinolone—psoriasis	3.43e-05	0.000524	CcSEcCtD
Eplerenone—Pain—Hydrocortisone—psoriasis	3.42e-05	0.000523	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.41e-05	0.00384	CbGpPWpGaD
Eplerenone—Insomnia—Triamcinolone—psoriasis	3.41e-05	0.00052	CcSEcCtD
Eplerenone—Infection—Dexamethasone—psoriasis	3.4e-05	0.000519	CcSEcCtD
Eplerenone—Infection—Betamethasone—psoriasis	3.4e-05	0.000519	CcSEcCtD
Eplerenone—Ill-defined disorder—Prednisone—psoriasis	3.39e-05	0.000517	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisolone—psoriasis	3.38e-05	0.000516	CcSEcCtD
Eplerenone—Anaemia—Prednisone—psoriasis	3.37e-05	0.000515	CcSEcCtD
Eplerenone—Shock—Dexamethasone—psoriasis	3.36e-05	0.000514	CcSEcCtD
Eplerenone—Shock—Betamethasone—psoriasis	3.36e-05	0.000514	CcSEcCtD
Eplerenone—Dyspnoea—Triamcinolone—psoriasis	3.36e-05	0.000513	CcSEcCtD
Eplerenone—Nervous system disorder—Dexamethasone—psoriasis	3.35e-05	0.000512	CcSEcCtD
Eplerenone—Nervous system disorder—Betamethasone—psoriasis	3.35e-05	0.000512	CcSEcCtD
Eplerenone—Angioedema—Prednisone—psoriasis	3.33e-05	0.000509	CcSEcCtD
Eplerenone—Dyspepsia—Triamcinolone—psoriasis	3.32e-05	0.000506	CcSEcCtD
Eplerenone—Nausea—Mycophenolic acid—psoriasis	3.31e-05	0.000505	CcSEcCtD
Eplerenone—Hyperhidrosis—Betamethasone—psoriasis	3.31e-05	0.000505	CcSEcCtD
Eplerenone—Hyperhidrosis—Dexamethasone—psoriasis	3.31e-05	0.000505	CcSEcCtD
Eplerenone—Feeling abnormal—Hydrocortisone—psoriasis	3.3e-05	0.000504	CcSEcCtD
Eplerenone—Malaise—Prednisone—psoriasis	3.29e-05	0.000502	CcSEcCtD
Eplerenone—Gastrointestinal pain—Hydrocortisone—psoriasis	3.27e-05	0.0005	CcSEcCtD
Eplerenone—Syncope—Prednisone—psoriasis	3.27e-05	0.0005	CcSEcCtD
Eplerenone—Tinnitus—Methotrexate—psoriasis	3.27e-05	0.000499	CcSEcCtD
Eplerenone—Cardiac disorder—Methotrexate—psoriasis	3.25e-05	0.000496	CcSEcCtD
Eplerenone—Fatigue—Triamcinolone—psoriasis	3.25e-05	0.000496	CcSEcCtD
Eplerenone—Asthenia—Cyclosporine—psoriasis	3.23e-05	0.000493	CcSEcCtD
Eplerenone—Pain—Triamcinolone—psoriasis	3.22e-05	0.000492	CcSEcCtD
Eplerenone—Loss of consciousness—Prednisone—psoriasis	3.21e-05	0.00049	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.2e-05	0.0036	CbGpPWpGaD
Eplerenone—Hypotension—Dexamethasone—psoriasis	3.19e-05	0.000488	CcSEcCtD
Eplerenone—Hypotension—Betamethasone—psoriasis	3.19e-05	0.000488	CcSEcCtD
Eplerenone—Pruritus—Cyclosporine—psoriasis	3.19e-05	0.000486	CcSEcCtD
Eplerenone—Angiopathy—Methotrexate—psoriasis	3.18e-05	0.000485	CcSEcCtD
Eplerenone—Abdominal pain—Hydrocortisone—psoriasis	3.16e-05	0.000483	CcSEcCtD
Eplerenone—Body temperature increased—Hydrocortisone—psoriasis	3.16e-05	0.000483	CcSEcCtD
Eplerenone—Mediastinal disorder—Methotrexate—psoriasis	3.16e-05	0.000482	CcSEcCtD
Eplerenone—Asthenia—Mycophenolate mofetil—psoriasis	3.15e-05	0.000481	CcSEcCtD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.15e-05	0.00355	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Betamethasone—psoriasis	3.11e-05	0.000476	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Dexamethasone—psoriasis	3.11e-05	0.000476	CcSEcCtD
Eplerenone—Pruritus—Mycophenolate mofetil—psoriasis	3.11e-05	0.000475	CcSEcCtD
Eplerenone—Myalgia—Prednisone—psoriasis	3.11e-05	0.000474	CcSEcCtD
Eplerenone—Arthralgia—Prednisone—psoriasis	3.11e-05	0.000474	CcSEcCtD
Eplerenone—Feeling abnormal—Triamcinolone—psoriasis	3.11e-05	0.000474	CcSEcCtD
Eplerenone—Insomnia—Betamethasone—psoriasis	3.09e-05	0.000472	CcSEcCtD
Eplerenone—Insomnia—Dexamethasone—psoriasis	3.09e-05	0.000472	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	3.08e-05	0.000471	CcSEcCtD
Eplerenone—Diarrhoea—Cyclosporine—psoriasis	3.08e-05	0.00047	CcSEcCtD
Eplerenone—Discomfort—Prednisone—psoriasis	3.07e-05	0.000469	CcSEcCtD
Eplerenone—Mental disorder—Methotrexate—psoriasis	3.07e-05	0.000469	CcSEcCtD
Eplerenone—Malnutrition—Methotrexate—psoriasis	3.05e-05	0.000466	CcSEcCtD
Eplerenone—Dyspepsia—Betamethasone—psoriasis	3.01e-05	0.00046	CcSEcCtD
Eplerenone—Dyspepsia—Dexamethasone—psoriasis	3.01e-05	0.00046	CcSEcCtD
Eplerenone—Diarrhoea—Mycophenolate mofetil—psoriasis	3.01e-05	0.000459	CcSEcCtD
Eplerenone—Body temperature increased—Triamcinolone—psoriasis	2.98e-05	0.000455	CcSEcCtD
Eplerenone—Dizziness—Cyclosporine—psoriasis	2.98e-05	0.000455	CcSEcCtD
Eplerenone—Infection—Prednisone—psoriasis	2.96e-05	0.000452	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Dexamethasone—psoriasis	2.95e-05	0.000451	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Betamethasone—psoriasis	2.95e-05	0.000451	CcSEcCtD
Eplerenone—Back pain—Methotrexate—psoriasis	2.95e-05	0.00045	CcSEcCtD
Eplerenone—Fatigue—Betamethasone—psoriasis	2.95e-05	0.00045	CcSEcCtD
Eplerenone—Fatigue—Dexamethasone—psoriasis	2.95e-05	0.00045	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CARM1—psoriasis	2.95e-05	0.00332	CbGpPWpGaD
Eplerenone—Shock—Prednisone—psoriasis	2.93e-05	0.000447	CcSEcCtD
Eplerenone—Pain—Betamethasone—psoriasis	2.92e-05	0.000446	CcSEcCtD
Eplerenone—Pain—Dexamethasone—psoriasis	2.92e-05	0.000446	CcSEcCtD
Eplerenone—Nervous system disorder—Prednisone—psoriasis	2.92e-05	0.000446	CcSEcCtD
Eplerenone—Dizziness—Mycophenolate mofetil—psoriasis	2.9e-05	0.000444	CcSEcCtD
Eplerenone—Skin disorder—Prednisone—psoriasis	2.89e-05	0.000442	CcSEcCtD
Eplerenone—Hyperhidrosis—Prednisone—psoriasis	2.88e-05	0.00044	CcSEcCtD
Eplerenone—Asthenia—Hydrocortisone—psoriasis	2.87e-05	0.000438	CcSEcCtD
Eplerenone—Vomiting—Cyclosporine—psoriasis	2.86e-05	0.000437	CcSEcCtD
Eplerenone—Rash—Cyclosporine—psoriasis	2.84e-05	0.000434	CcSEcCtD
Eplerenone—Dermatitis—Cyclosporine—psoriasis	2.84e-05	0.000433	CcSEcCtD
Eplerenone—Pruritus—Hydrocortisone—psoriasis	2.83e-05	0.000432	CcSEcCtD
Eplerenone—Ill-defined disorder—Methotrexate—psoriasis	2.83e-05	0.000432	CcSEcCtD
Eplerenone—Headache—Cyclosporine—psoriasis	2.82e-05	0.000431	CcSEcCtD
Eplerenone—Anaemia—Methotrexate—psoriasis	2.82e-05	0.00043	CcSEcCtD
Eplerenone—Feeling abnormal—Dexamethasone—psoriasis	2.82e-05	0.00043	CcSEcCtD
Eplerenone—Feeling abnormal—Betamethasone—psoriasis	2.82e-05	0.00043	CcSEcCtD
Eplerenone—Gastrointestinal pain—Betamethasone—psoriasis	2.8e-05	0.000427	CcSEcCtD
Eplerenone—Gastrointestinal pain—Dexamethasone—psoriasis	2.8e-05	0.000427	CcSEcCtD
Eplerenone—Vomiting—Mycophenolate mofetil—psoriasis	2.79e-05	0.000426	CcSEcCtD
Eplerenone—Rash—Mycophenolate mofetil—psoriasis	2.77e-05	0.000423	CcSEcCtD
Eplerenone—Dermatitis—Mycophenolate mofetil—psoriasis	2.77e-05	0.000422	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.76e-05	0.00311	CbGpPWpGaD
Eplerenone—Headache—Mycophenolate mofetil—psoriasis	2.75e-05	0.00042	CcSEcCtD
Eplerenone—Malaise—Methotrexate—psoriasis	2.75e-05	0.00042	CcSEcCtD
Eplerenone—Diarrhoea—Hydrocortisone—psoriasis	2.74e-05	0.000418	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Prednisone—psoriasis	2.71e-05	0.000414	CcSEcCtD
Eplerenone—Dizziness—Prednisolone—psoriasis	2.71e-05	0.000414	CcSEcCtD
Eplerenone—Asthenia—Triamcinolone—psoriasis	2.7e-05	0.000413	CcSEcCtD
Eplerenone—Abdominal pain—Betamethasone—psoriasis	2.7e-05	0.000413	CcSEcCtD
Eplerenone—Abdominal pain—Dexamethasone—psoriasis	2.7e-05	0.000413	CcSEcCtD
Eplerenone—Body temperature increased—Dexamethasone—psoriasis	2.7e-05	0.000413	CcSEcCtD
Eplerenone—Body temperature increased—Betamethasone—psoriasis	2.7e-05	0.000413	CcSEcCtD
Eplerenone—Insomnia—Prednisone—psoriasis	2.69e-05	0.000411	CcSEcCtD
Eplerenone—Nausea—Cyclosporine—psoriasis	2.67e-05	0.000408	CcSEcCtD
Eplerenone—Pruritus—Triamcinolone—psoriasis	2.67e-05	0.000407	CcSEcCtD
Eplerenone—Cough—Methotrexate—psoriasis	2.66e-05	0.000406	CcSEcCtD
Eplerenone—Dizziness—Hydrocortisone—psoriasis	2.65e-05	0.000404	CcSEcCtD
Eplerenone—Dyspepsia—Prednisone—psoriasis	2.62e-05	0.0004	CcSEcCtD
Eplerenone—Nausea—Mycophenolate mofetil—psoriasis	2.61e-05	0.000398	CcSEcCtD
Eplerenone—Myalgia—Methotrexate—psoriasis	2.6e-05	0.000396	CcSEcCtD
Eplerenone—Chest pain—Methotrexate—psoriasis	2.6e-05	0.000396	CcSEcCtD
Eplerenone—Arthralgia—Methotrexate—psoriasis	2.6e-05	0.000396	CcSEcCtD
Eplerenone—Rash—Prednisolone—psoriasis	2.58e-05	0.000394	CcSEcCtD
Eplerenone—Dermatitis—Prednisolone—psoriasis	2.58e-05	0.000394	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.58e-05	0.000394	CcSEcCtD
Eplerenone—Fatigue—Prednisone—psoriasis	2.57e-05	0.000392	CcSEcCtD
Eplerenone—Headache—Prednisolone—psoriasis	2.57e-05	0.000392	CcSEcCtD
Eplerenone—Discomfort—Methotrexate—psoriasis	2.56e-05	0.000392	CcSEcCtD
Eplerenone—NR3C2—Generic Transcription Pathway—PPARG—psoriasis	2.55e-05	0.00287	CbGpPWpGaD
Eplerenone—Constipation—Prednisone—psoriasis	2.55e-05	0.000389	CcSEcCtD
Eplerenone—Vomiting—Hydrocortisone—psoriasis	2.54e-05	0.000389	CcSEcCtD
Eplerenone—Rash—Hydrocortisone—psoriasis	2.52e-05	0.000385	CcSEcCtD
Eplerenone—Dermatitis—Hydrocortisone—psoriasis	2.52e-05	0.000385	CcSEcCtD
Eplerenone—Headache—Hydrocortisone—psoriasis	2.51e-05	0.000383	CcSEcCtD
Eplerenone—Dizziness—Triamcinolone—psoriasis	2.49e-05	0.00038	CcSEcCtD
Eplerenone—Infection—Methotrexate—psoriasis	2.47e-05	0.000377	CcSEcCtD
Eplerenone—Feeling abnormal—Prednisone—psoriasis	2.45e-05	0.000375	CcSEcCtD
Eplerenone—Asthenia—Dexamethasone—psoriasis	2.45e-05	0.000375	CcSEcCtD
Eplerenone—Asthenia—Betamethasone—psoriasis	2.45e-05	0.000375	CcSEcCtD
Eplerenone—Nervous system disorder—Methotrexate—psoriasis	2.44e-05	0.000373	CcSEcCtD
Eplerenone—Gastrointestinal pain—Prednisone—psoriasis	2.43e-05	0.000372	CcSEcCtD
Eplerenone—Nausea—Prednisolone—psoriasis	2.43e-05	0.000372	CcSEcCtD
Eplerenone—Pruritus—Dexamethasone—psoriasis	2.42e-05	0.000369	CcSEcCtD
Eplerenone—Pruritus—Betamethasone—psoriasis	2.42e-05	0.000369	CcSEcCtD
Eplerenone—Skin disorder—Methotrexate—psoriasis	2.42e-05	0.000369	CcSEcCtD
Eplerenone—Hyperhidrosis—Methotrexate—psoriasis	2.41e-05	0.000367	CcSEcCtD
Eplerenone—Vomiting—Triamcinolone—psoriasis	2.4e-05	0.000366	CcSEcCtD
Eplerenone—Nausea—Hydrocortisone—psoriasis	2.38e-05	0.000363	CcSEcCtD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.38e-05	0.00268	CbGpPWpGaD
Eplerenone—Rash—Triamcinolone—psoriasis	2.38e-05	0.000363	CcSEcCtD
Eplerenone—Dermatitis—Triamcinolone—psoriasis	2.37e-05	0.000362	CcSEcCtD
Eplerenone—Headache—Triamcinolone—psoriasis	2.36e-05	0.00036	CcSEcCtD
Eplerenone—Body temperature increased—Prednisone—psoriasis	2.35e-05	0.000359	CcSEcCtD
Eplerenone—Abdominal pain—Prednisone—psoriasis	2.35e-05	0.000359	CcSEcCtD
Eplerenone—Diarrhoea—Dexamethasone—psoriasis	2.34e-05	0.000357	CcSEcCtD
Eplerenone—Diarrhoea—Betamethasone—psoriasis	2.34e-05	0.000357	CcSEcCtD
Eplerenone—Hypotension—Methotrexate—psoriasis	2.33e-05	0.000355	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Methotrexate—psoriasis	2.27e-05	0.000346	CcSEcCtD
Eplerenone—Dizziness—Betamethasone—psoriasis	2.26e-05	0.000345	CcSEcCtD
Eplerenone—Dizziness—Dexamethasone—psoriasis	2.26e-05	0.000345	CcSEcCtD
Eplerenone—Insomnia—Methotrexate—psoriasis	2.25e-05	0.000344	CcSEcCtD
Eplerenone—Nausea—Triamcinolone—psoriasis	2.24e-05	0.000342	CcSEcCtD
Eplerenone—Dyspnoea—Methotrexate—psoriasis	2.22e-05	0.000339	CcSEcCtD
Eplerenone—Dyspepsia—Methotrexate—psoriasis	2.19e-05	0.000334	CcSEcCtD
Eplerenone—Vomiting—Dexamethasone—psoriasis	2.17e-05	0.000332	CcSEcCtD
Eplerenone—Vomiting—Betamethasone—psoriasis	2.17e-05	0.000332	CcSEcCtD
Eplerenone—Rash—Betamethasone—psoriasis	2.16e-05	0.000329	CcSEcCtD
Eplerenone—Rash—Dexamethasone—psoriasis	2.16e-05	0.000329	CcSEcCtD
Eplerenone—Dermatitis—Betamethasone—psoriasis	2.15e-05	0.000329	CcSEcCtD
Eplerenone—Dermatitis—Dexamethasone—psoriasis	2.15e-05	0.000329	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Methotrexate—psoriasis	2.15e-05	0.000328	CcSEcCtD
Eplerenone—Fatigue—Methotrexate—psoriasis	2.15e-05	0.000328	CcSEcCtD
Eplerenone—Headache—Dexamethasone—psoriasis	2.14e-05	0.000327	CcSEcCtD
Eplerenone—Headache—Betamethasone—psoriasis	2.14e-05	0.000327	CcSEcCtD
Eplerenone—Asthenia—Prednisone—psoriasis	2.14e-05	0.000326	CcSEcCtD
Eplerenone—Pain—Methotrexate—psoriasis	2.13e-05	0.000325	CcSEcCtD
Eplerenone—Pruritus—Prednisone—psoriasis	2.11e-05	0.000322	CcSEcCtD
Eplerenone—Feeling abnormal—Methotrexate—psoriasis	2.05e-05	0.000313	CcSEcCtD
Eplerenone—Diarrhoea—Prednisone—psoriasis	2.04e-05	0.000311	CcSEcCtD
Eplerenone—Gastrointestinal pain—Methotrexate—psoriasis	2.03e-05	0.000311	CcSEcCtD
Eplerenone—Nausea—Dexamethasone—psoriasis	2.03e-05	0.00031	CcSEcCtD
Eplerenone—Nausea—Betamethasone—psoriasis	2.03e-05	0.00031	CcSEcCtD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.01e-05	0.00227	CbGpPWpGaD
Eplerenone—Dizziness—Prednisone—psoriasis	1.97e-05	0.000301	CcSEcCtD
Eplerenone—Abdominal pain—Methotrexate—psoriasis	1.97e-05	0.0003	CcSEcCtD
Eplerenone—Body temperature increased—Methotrexate—psoriasis	1.97e-05	0.0003	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—NDUFA5—psoriasis	1.91e-05	0.00216	CbGpPWpGaD
Eplerenone—Vomiting—Prednisone—psoriasis	1.89e-05	0.000289	CcSEcCtD
Eplerenone—Rash—Prednisone—psoriasis	1.88e-05	0.000287	CcSEcCtD
Eplerenone—Dermatitis—Prednisone—psoriasis	1.88e-05	0.000286	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—CARM1—psoriasis	1.87e-05	0.00211	CbGpPWpGaD
Eplerenone—Headache—Prednisone—psoriasis	1.87e-05	0.000285	CcSEcCtD
Eplerenone—Asthenia—Methotrexate—psoriasis	1.79e-05	0.000273	CcSEcCtD
Eplerenone—Nausea—Prednisone—psoriasis	1.77e-05	0.00027	CcSEcCtD
Eplerenone—Pruritus—Methotrexate—psoriasis	1.76e-05	0.000269	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—VDR—psoriasis	1.76e-05	0.00198	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.75e-05	0.00197	CbGpPWpGaD
Eplerenone—Diarrhoea—Methotrexate—psoriasis	1.7e-05	0.00026	CcSEcCtD
Eplerenone—Dizziness—Methotrexate—psoriasis	1.65e-05	0.000251	CcSEcCtD
Eplerenone—CYP3A7—Metabolism—CYP2S1—psoriasis	1.63e-05	0.00183	CbGpPWpGaD
Eplerenone—Vomiting—Methotrexate—psoriasis	1.58e-05	0.000242	CcSEcCtD
Eplerenone—Rash—Methotrexate—psoriasis	1.57e-05	0.00024	CcSEcCtD
Eplerenone—Dermatitis—Methotrexate—psoriasis	1.57e-05	0.000239	CcSEcCtD
Eplerenone—Headache—Methotrexate—psoriasis	1.56e-05	0.000238	CcSEcCtD
Eplerenone—Nausea—Methotrexate—psoriasis	1.48e-05	0.000226	CcSEcCtD
Eplerenone—CYP3A5—Metabolism—NDUFA5—psoriasis	1.38e-05	0.00156	CbGpPWpGaD
Eplerenone—NR3C2—Gene Expression—PPARG—psoriasis	1.23e-05	0.00138	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2S1—psoriasis	1.18e-05	0.00133	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CAT—psoriasis	1.15e-05	0.0013	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—APOE—psoriasis	8.95e-06	0.00101	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CARM1—psoriasis	7.94e-06	0.000896	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—PPARG—psoriasis	7.79e-06	0.000879	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—NDUFA5—psoriasis	6.43e-06	0.000725	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CARM1—psoriasis	5.74e-06	0.000647	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2S1—psoriasis	5.46e-06	0.000616	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CAT—psoriasis	4.88e-06	0.000551	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—APOE—psoriasis	3.79e-06	0.000428	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CAT—psoriasis	3.53e-06	0.000398	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—PPARG—psoriasis	3.31e-06	0.000373	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—APOE—psoriasis	2.74e-06	0.000309	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CARM1—psoriasis	2.67e-06	0.000301	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—PPARG—psoriasis	2.39e-06	0.00027	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CAT—psoriasis	1.64e-06	0.000185	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—APOE—psoriasis	1.28e-06	0.000144	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—PPARG—psoriasis	1.11e-06	0.000125	CbGpPWpGaD
